News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Reports Progress on Key Clinical Development Programs

October 15, 2019

Affimed to Participate in Investor Conferences in September

August 28, 2019

Affimed Reports Second Quarter 2019 Financial and Operational Results

August 7, 2019

Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019

July 31, 2019

Affimed Added to the Russell 2000®, 3000® and Microcap Indexes

July 1, 2019

Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019

June 24, 2019

Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland

June 12, 2019

Affimed Announces Annual General Meeting of Shareholders

June 4, 2019

Affimed to Present at the Jefferies 2019 Healthcare Conference

May 29, 2019

Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress

May 22, 2019

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Events

All

Scientific

Investors

20Nov

Jefferies 2019 London Healthcare Conference

November 20 - 21, 2019 (London, UK)
Presenter: Adi Hoess

09Dec

Antibody Engineering & Therapeutics

December 9 - 13, 2019 (San Diego, USA)
Presenter: Michael Tesar

Webcasts
More events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.